Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Congress
House Takes Action on Opioid-Related CME Measures
We have always been strong proponents of continuing medical education (CME), as we believe it is the solution to many different…
House Introduces Bill to Require CME for Controlled Substance Prescribing
House of Representatives member Representative Susan W. Brooks recently introduced the ADAPT Act of 2018. The ADAPT Act (Abuse…
Senate Holds Hearing on 340B Drug Pricing Program
On Thursday, March 15, 2018, the United States Senate Committee on Health, Education, Labor & Pensions held a hearing…
House of Representatives Holds Two-Day Hearing on Opioids
Recently the Committee on Energy and Commerce Subcommittee on Health held a hearing entitled, “Combating the Opioid Crisis:…
House Subcommittee on Health Holds Hearing on MACRA
On March 21, the House Ways and Means Subcommittee on Health held a hearing focused on the implementation of the Medicare Access…
House Finally Passes Right to Try. If First You Don’t Succeed, Try, Try…
The United States Senate previously approved legislation that would allow the terminally ill to access experimental…
Teva and McCaskill: A Game of Cat and Mouse
In Summer 2017, we wrote about Senator Claire McCaskill’s request to Teva Pharmaceutical Industries that they provide…
CARA 2.0 Introduced by Bipartisan Group of Senators
A bipartisan group of senators have introduced legislation framed as a follow-up bill to the Comprehensive Addiction and Recovery…
Senators Once Again Taking Up the DTC Tax Write-Off
Senator Claire McCaskill recently introduced legislation that would eliminate the ability of drug manufacturers to deduct the cost…
E&C House Subcommittee Slated to Review Eight Bills on Opioids
Recently, the House Energy & Commerce Health Subcommittee announced that it will hold a hearing on Wednesday, February 28,…